Gus Cairns Editor

Gus joined the editorial team in 2009 and has previously edited HIV Treatment Update and Preventing HIV. He currently focuses on the PrEP in Europe Initiative and on news reporting.

Injectable & long-acting HIV treatment

Injectable HIV therapy would have to cost less than $131 a year to be cost-effective in Africa

Drug interactions & pharmacokinetics

PrEP does not lower hormone levels in young transgender people, but lower PrEP levels seen in some transgender women

Finance & funding

To be cost-effective, injectable PrEP can only cost about $3000 more than US generic oral PrEP

PrEP science

Interactions between PrEP and gender-affirming hormone therapy

PrEP science

HPTN 083: Injectable PrEP can make breakthrough infections hard to detect

Injectable & long-acting PrEP

Reformulated islatravir implant should provide PrEP for over a year

PrEP

Sex, PrEP and HIV in trans and non-binary people

The search for an HIV prevention vaccine

Where next for HIV vaccines and antibody therapies?

PrEP programmes & uptake

African studies explore reasons to start, stick with or stop PrEP

Injectable & long-acting PrEP

Once-a-month PrEP pill easily passes its first big test

Antibody-based prevention

Antibody-based PrEP did not stop most types of HIV – but is still hailed as a ‘game changer’

PrEP policies & guidelines

European PrEP programmes face two big issues: how to get more people coming forward, and how to serve them if they do

PrEP programmes & uptake

Bacterial STI rates rose in the year before starting PrEP, but not during PrEP, Australian study finds

People & personal stories

Anthony Fauci: “I don’t do this because I’m a hero. I do it because it’s necessary.”

PrEP policies & guidelines

Is reducing anxiety a legitimate indication for PrEP in itself?

Undetectable viral load & treatment as prevention

Undetectable viral load and transmission – information for HIV-negative people

Injectable & long-acting PrEP

Study of injectable PrEP reports the best efficacy seen yet for any form of PrEP in women

Hepatitis & HIV

European HIV doctors conduct their first-ever region-wide audit of services